GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>but what is the incentive for keeping good news private?<

This is what happens when a company releases data
publicly that is intended to be presented at a medical
conference:

http://yahoo.reuters.com/news/articlehybrid.aspx?storyID=urn:newsml:reuters.com:20061110:MTFH88081_2...

>>
Pfizer Presentation Pulled from AHA Conference

Fri Nov 10, 2006 6:42 PM ET
By Bill Berkrot

NEW YORK, Nov 10 (Reuters) - The American Heart Association said on Friday it would not allow Pfizer Inc. <PFE> to present a study on its closely watched drug torcetrapib at the organization's scientific meeting next week after the drugmaker broke an AHA embargo.

The heart association had pulled an abstract with data from the study of the cholesterol drug from its meeting planning Web site in response to Pfizer issuing some of the data early, in an Oct. 31 news release.

…"Today after discussions among AHA staff and leadership the AHA has decided to pull (Pfizer's) presentation in accordance with AHA embargo policy."

Pfizer said it had discussions with AHA officials on Friday and extended an apology.

"We certainly expressed that we understood their position," Pfizer spokesman Paul Fitzhenry said. "We will look for other opportunities to present the abstract and we plan to present it at our November 30 analyst meeting."
<<